Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.68 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.53 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31688985 | 1.00 | TAAR1 (0.68) | TAAR1HRH4HRH3HTR1AMMP2 | |
| SCHEMBL957832 | 0.83 | TAAR1 (0.55) | TAAR1HRH3HTR1ACYP1A2ADRA2A | |
| SCHEMBL9243 | 0.81 | TAAR1 (1.00) | TAAR1HTR1ACYP2D6ADRA2AADRA2B | |
| SCHEMBL7381000 | 0.80 | TAAR1 (0.47) | TAAR1HRH4HRH3HTTCYP2D6 | |
| SCHEMBL1795069 | 0.80 | CYP1A2 (0.66) | TAAR1HTTCYP2D6CYP1A2ADRA2C | |
| SCHEMBL31414967 | 0.79 | TAAR1 (0.75) | TAAR1HTR1ACYP2D6ADRA2AADRA2B | |
| Bromide SCHEMBL29135558 | 0.79 | TAAR1 (0.96) | TAAR1HTR1ACYP2D6ADRA2AADRA2B | |
| Ammonia Solution, Strong SCHEMBL27639428 | 0.79 | TAAR1 (0.96) | TAAR1HTR1ACYP2D6ADRA2AADRA2B | |
| Hydrochloric Acid SCHEMBL27290500 | 0.79 | TAAR1 (0.96) | TAAR1HTR1ACYP2D6ADRA2AADRA2B | |
| Methane SCHEMBL28185797 | 0.79 | TAAR1 (0.96) | TAAR1HTR1ACYP2D6ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2977406-B1 | CURABLE COMPOSITION | LG CHEMICAL LTD (KR) | 2024-01-24 | — | — | EP | disclosed |
| EP-3692088-B1 | LATENT CATALYSTS WITH CHELATE LIGANDS FOR POLYMERIZATION OF DICYCLOPENTADIENE (DCPD) | UNIV STUTTGART (DE) | 2023-08-02 | — | — | EP | disclosed |
| US-10457842-B2 | Curable composition | LG CHEM, LTD. (KR) | 2019-10-29 | — | — | US | disclosed |
| EP-2977406-A1 | CURABLE COMPOSITION | LG Chem, Ltd. (KR) | 2016-01-27 | — | — | EP | disclosed |
| US-20150368528-A1 | CURABLE COMPOSITION | LG CHEM, LTD. (KR) | 2015-12-24 | — | — | US | disclosed |
| EP-1417177-A4 | ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | BRISTOL MYERS SQUIBB PHARMA CO (US) | 2005-10-19 | — | — | EP | disclosed |
| CN-1553900-A | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents | ��ʱ��ʩ����ҩ��˾ | 2004-12-08 | — | — | CN | disclosed |
| EP-1417177-A2 | ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | Bristol-Myers Squibb Pharma Company (US) | 2004-05-12 | — | — | EP | disclosed |
| CN-1477960-A | EPA receptor inhibitors to treat rheumatoid arthritis | — | 2004-02-25 | — | — | CN | disclosed |
| WO-2003007883-A2 | ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2003-01-30 | — | — | WO | disclosed |
| CN-1297442-A | 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents | DU PONT PHARM CO (US) | 2001-05-30 | — | — | CN | disclosed |
| EP-1071668-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | Du Pont Pharmaceuticals Company (US) | 2001-01-31 | — | — | EP | disclosed |
| WO-1999054308-A1 | 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS | DU PONT PHARMACEUTICALS COMPANY (US) | 1999-10-28 | — | — | WO | disclosed |